Attorney General Chris Koster announced Wednesday that Missouri will receive $1.5 million for its share of a national settlement with Wyeth Pharmaceuticals. The settlement resolves federal civil and criminal litigation against the company, alleging that it promoted the sale and use of Rapamune for unapproved or off-label purposes. Rapamune is an FDA approved kidney transplant drug prescribed to prevent the body from rejecting a donor organ that has been transplanted into the body. State and federal Medicaid fraud investigators began looking at Wyeth following the filing of federal complaints by three whistleblowers alleging the company was violating the False Claims Act and various state false claims statutes. Wyeth agreed to pay the states and the federal government over $257 million in civil damages and penalties, with over $60 million to go to the Medicaid program.
Return to: Local News Blog